UNKNOWN KNEE
Report
- Report Number
- 0001825034-2015-02267
- Event Type
- Injury
- Date Received
- May 27, 2015
- Report Date
- April 29, 2015
- Manufacturer
- BIOMET UK LTD
- Product Code
- NRA
- PMA / PMN Number
- PN/A
- Removal / Correction Number
- N/A
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- UK
- Reporter Occupation
- PHYSICIAN
Narratives
THE PRODUCT IDENTIFICATION NECESSARY TO REVIEW MANUFACTURING HISTORY WAS NOT PROVIDED. CURRENT INFORMATION IS INSUFFICIENT TO PERMIT A CONCLUSION AS TO THE CAUSE OF THE EVENT. THE FOLLOWING SECTIONS COULD NOT BE COMPLETED WITH THE LIMITED INFORMATION PROVIDED. DATE OF EVENT - UNKNOWN. EXPIRATION DATE/LOT NUMBER - UNKNOWN. DATE IMPLANTED - UNKNOWN. DATE EXPLANTED - UNKNOWN. INITIAL REPORTER - THE ARTICLE WAS WRITTEN BY H PANDIT IN BONE JOINT SURG (BR} 2011;93-8:198¿204. PMA/510(K) NUMBER ¿ UNKNOWN. MANUFACTURE DATE ¿ UNKNOWN. THIS INFORMATION WAS ORIGINALLY REPORTED ON 1825034-2015-02246 WHICH REFERENCED A JOURNAL ARTICLE WRITTEN ON A STUDY THAT THIS PATIENT TOOK PART IN.
INFORMATION WAS RECEIVED BASED ON REVIEW OF A JOURNAL ARTICLE ENTITLED, "MINIMALLY INVASIVE OXFORD PHASE 3 UNICOMPARTMENTAL KNEE REPLACEMENT." THIS PROSPECTIVE STUDY DESCRIBES THE OUTCOME OF THE FIRST 1000 PHASE 3 OXFORD MEDIAL UNICOMPARTMENTAL KNEE REPLACEMENTS IMPLANTED USING A MINIMALLY INVASIVE SURGICAL APPROACH FOR THE RECOMMENDED INDICATIONS BY TWO SURGEONS AND FOLLOWED UP INDEPENDENTLY. A PATIENT WAS IDENTIFIED IN THE ARTICLE THAT UNDERWENT PARTIAL KNEE ARTHROPLASTY ON AN UNKNOWN SIDE ON AN UNKNOWN DATE. PATIENT FOLLOW-UP RESULTS PROVIDED AT 8.97 YEAR POST-IMPLANTATION INDICATES PATIENT UNDERWENT A REVISION SURGERY ON AN UNKNOWN DATE DUE TO PAIN. THERE HAS BEEN NO FURTHER INFORMATION PROVIDED AND THE PATIENT OUTCOME IS UNKNOWN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 343027 | UNKNOWN KNEE | PROSTHESIS, KNEE | NRA | BIOMET UK LTD | N/A | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| R |